BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goemann IM, Romitti M, Meyer ELS, Wajner SM, Maia AL. Role of thyroid hormones in the neoplastic process: an overview. Endocr Relat Cancer 2017;24:R367-85. [PMID: 28928142 DOI: 10.1530/ERC-17-0192] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kostopoulos G, Doundoulakis I, Antza C, Bouras E, Nirantharakumar K, Tsiachris D, Thomas GN, Lip GYH, Toulis KA. Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis. Endocr Relat Cancer 2021;28:325-35. [PMID: 33794503 DOI: 10.1530/ERC-20-0496] [Reference Citation Analysis]
2 Yu S, Zhou W, Cheng X, Meng Q, Li H, Hou L, Lu J, Xie S, Cheng Q, Zhang C, Qiu L. Comparison of Six Automated Immunoassays With Isotope-Diluted Liquid Chromatography-Tandem Mass Spectrometry for Total Thyroxine Measurement. Ann Lab Med 2019;39:381-7. [PMID: 30809984 DOI: 10.3343/alm.2019.39.4.381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Krashin E, Piekiełko-Witkowska A, Ellis M, Ashur-Fabian O. Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies. Front Endocrinol (Lausanne) 2019;10:59. [PMID: 30814976 DOI: 10.3389/fendo.2019.00059] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 16.7] [Reference Citation Analysis]
4 Schiera G, Di Liegro CM, Di Liegro I. Involvement of Thyroid Hormones in Brain Development and Cancer. Cancers (Basel) 2021;13:2693. [PMID: 34070729 DOI: 10.3390/cancers13112693] [Reference Citation Analysis]
5 Cayrol F, Sterle HA, Díaz Flaqué MC, Barreiro Arcos ML, Cremaschi GA. Non-genomic Actions of Thyroid Hormones Regulate the Growth and Angiogenesis of T Cell Lymphomas. Front Endocrinol (Lausanne) 2019;10:63. [PMID: 30814977 DOI: 10.3389/fendo.2019.00063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
6 Deligiorgi MV, Trafalis DT. The Intriguing Thyroid Hormones-Lung Cancer Association as Exemplification of the Thyroid Hormones-Cancer Association: Three Decades of Evolving Research. Int J Mol Sci 2021;23:436. [PMID: 35008863 DOI: 10.3390/ijms23010436] [Reference Citation Analysis]
7 Uchuya-Castillo J, Aznar N, Frau C, Martinez P, Le Nevé C, Marisa L, Penalva LOF, Laurent-Puig P, Puisieux A, Scoazec JY, Samarut J, Ansieau S, Plateroti M. Increased expression of the thyroid hormone nuclear receptor TRα1 characterizes intestinal tumors with high Wnt activity. Oncotarget 2018;9:30979-96. [PMID: 30123421 DOI: 10.18632/oncotarget.25741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Zhao Y, Chen P, Lv HJ, Wu Y, Liu S, Deng X, Shi B, Fu J. Comprehensive Analysis of Expression and Prognostic Value of Selenoprotein Genes in Thyroid Cancer. Genet Test Mol Biomarkers 2022;26:159-73. [PMID: 35481968 DOI: 10.1089/gtmb.2021.0123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gionfra F, De Vito P, Pallottini V, Lin HY, Davis PJ, Pedersen JZ, Incerpi S. The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer. Front Endocrinol (Lausanne) 2019;10:532. [PMID: 31543862 DOI: 10.3389/fendo.2019.00532] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
10 Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Recent Advances in Thyroid Hormone Regulation: Toward a New Paradigm for Optimal Diagnosis and Treatment. Front Endocrinol (Lausanne) 2017;8:364. [PMID: 29375474 DOI: 10.3389/fendo.2017.00364] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
11 Deligiorgi MV, Trafalis DT. The continuum of care of anticancer treatment-induced hypothyroidism in patients with solid non thyroid tumors: time for an intimate collaboration between oncologists and endocrinologists. Expert Rev Clin Pharmacol 2022. [PMID: 35757870 DOI: 10.1080/17512433.2022.2093714] [Reference Citation Analysis]
12 Fröhlich E, Wahl R. Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients. Front Endocrinol (Lausanne) 2021;12:587518. [PMID: 33981284 DOI: 10.3389/fendo.2021.587518] [Reference Citation Analysis]
13 Kojima Y, Kondo Y, Fujishita T, Mishiro-Sato E, Kajino-Sakamoto R, Taketo MM, Aoki M. Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in ApcΔ716 mutant mice. Cancer Sci 2019;110:2520-8. [PMID: 31215118 DOI: 10.1111/cas.14100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Tanase DM, Gosav EM, Neculae E, Costea CF, Ciocoiu M, Hurjui LL, Tarniceriu CC, Floria M. Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options. Int J Mol Sci 2020;21:E5927. [PMID: 32824723 DOI: 10.3390/ijms21165927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Bevinakoppamath S, Saleh Ahmed AM, Ramachandra SC, Vishwanath P, Prashant A. Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer. Front Pharmacol 2021;12:618172. [PMID: 33935708 DOI: 10.3389/fphar.2021.618172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Deligiorgi MV, Trafalis DT. The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum. J Clin Med 2022;11:3417. [PMID: 35743483 DOI: 10.3390/jcm11123417] [Reference Citation Analysis]
17 Goemann IM, Marczyk VR, Recamonde-Mendoza M, Wajner SM, Graudenz MS, Maia AL. Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer. Sci Rep 2020;10:13914. [PMID: 32807826 DOI: 10.1038/s41598-020-70892-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, Lifschytz T, Weisz A, Mondal S, Ungati H, Katzav A, Kidron D, Mugesh G, Ellis M, Lerer B, Ashur-Fabian O. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene 2021;40:6248-57. [PMID: 34556811 DOI: 10.1038/s41388-021-02020-z] [Reference Citation Analysis]
19 Barr CE, Njoku K, Hotchkies L, Ryan NAJ, Wan YL, Davies DA, Razvi S, Crosbie EJ. Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study. Cancers (Basel) 2021;13:5444. [PMID: 34771605 DOI: 10.3390/cancers13215444] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tran TV, Maringe C, Benitez Majano S, Rachet B, Boutron-Ruault MC, Journy N. Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort. Cancer Med 2021;10:4604-14. [PMID: 34041857 DOI: 10.1002/cam4.3978] [Reference Citation Analysis]